Feedback / Questions
Augtyro (repotrectinib) - BMS
Augtyro: Newly added patents in Orange Book
(Orange Book)
-
Nov 17, 2025 -
Expiry on Jan 23, 2035
Patent
•
Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • Thoracic Cancer
https://www.accessdata.fda.gov/scripts/cder/ob/search_patent.cfm?listed=new
Nov 17, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious